We invite abstract submissions on all aspects of neuropathology.
|Call for Abstracts Open Date||February 7, 2018|
|Abstract Submission Deadline
(Application Deadline for Travel Awards)
|March 31, 2018|
|Late Breakers Abstract Submission Deadline
(Basically intended for poster presentations only)
|April 19, 2018|
|Author Notification||May 18, 2018|
|Congress Dates||September 23 - 27, 2018|
A Gateway to Modern Neuroscience
The person submitting the abstract identifies the author who will be designated as the Presenter. The registered Corresponding Person will serve as primary contact on the abstract.
It is the responsibility of the Corresponding Person to communicate with all authors regarding acceptance of the abstract and to obtain conflict of interest disclosures from the authors.
Please note that in order to be designated as a Presenter, it is a must to register for participation in ICN2018 before a submission of the abstract. Online registration for ICN2018 will be available from the Registration page. When you complete your online registration with a required payment of registration fees, an email will be sent to you to inform you how to submit your abstract online to ICN2018.
Slide presentations will be given using Microsoft PowerPoint software. Further details on oral presentation will be sent upon acceptance of abstract.
Presenting author must attend and be available during your assigned poster session (30 minutes). Further details on poster dimensions will be sent upon acceptance of abstract.
We anticipate offering travel awards for selected abstracts.
If you want to apply for the award, please submit your abstract by March 31, 2018.
This award is given in recognition of outstanding endeavors by young researchers in their activities and to encourage continued research careers related neuropathology. For this program, a limited number of awards will be made available to the researchers under the age of 40 from low to middle income countries who submit original abstracts in all basic and clinical research fields of neuropathology.
(The winners of awards will be announced and presented during the congress)
The award will be given travel grants and will be granted to selected winners of qualified researchers and a registration fee for the congress will be waived.
For details, please click here.
Please select one in the following categories.
|1||Alzheimer’s disease||17||Molecular pathology and bioinformatics|
|2||Tauopathy||18||Adult diffuse gliomas|
|3||TDP-43 proteinopathy||19||Pediatric diffuse gliomas|
|4||Alpha-synucleinopathy||20||Benign and low grade neuroepithelial tumors|
|5||Spinocerebellar ataxia||21||Ependymomas and related tumors|
|6||Other neurodegeneration||22||Tumors of pineal region|
|7||Brain bank & cohort study||23||Embryonal tumors|
|8||Inflammation & demyelination||24||Meningiomas and related mesenchymal tumors|
|9||Vascular disease & trauma||25||Tumors of peripheral nervous system|
|10||Infection & prion disease||26||Lymphomas and other hematopoietic tumors|
|11||Pediatric disease||27||Germ cell tumors|
|12||Epilepsy||28||Familial tumor syndromes|
|13||Peripheral neuropathy||29||Pituitary adenoma and other sellar lesions|
|14||Muscle disease||30||WHO classification, CNS & Pituitary|
|15||Basic neuropathology||31||Other topics|
|16||Education in neuropathology|
All presentations will be accepted based on quality, relevance and space availability after peer-review by the Scientific Program Committee.
Abstracts received from February 7, 2018 through March 31, 2018 and Late-Breaking Abstracts received from April 1, 2018 to April 19, 2018 will be peer-reviewed by the Scientific Program Committee.
Notice of acceptance or rejection, the date of presentation and the presentation format (oral or poster) will be made to the Corresponding Person around May 18, 2018.
Please submit your abstract after taking the above instructions into consideration.